Dosing, monitoring, and safety of growth hormone-replacement therapy in adults with growth hormone deficiency
被引:1
|
作者:
Blethen, S
论文数: 0引用数: 0
h-index: 0
机构:
Genentech Inc, Post Mkt Studies, S San Francisco, CA 94080 USAGenentech Inc, Post Mkt Studies, S San Francisco, CA 94080 USA
Blethen, S
[1
]
机构:
[1] Genentech Inc, Post Mkt Studies, S San Francisco, CA 94080 USA
来源:
ENDOCRINOLOGIST
|
1998年
/
8卷
/
06期
关键词:
D O I:
10.1097/00019616-199811001-00008
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The main goal of growth hormone (GH)-replacement therapy for adults with growth hormone deficiency is to achieve physiologic replacement, GH secretion varies from day to day and depends on a number of factors including age, sex, body composition, and sleep patterns. This variability means that GH dosage must be individualized and adjusted in response to efficacy and safety outcomes, The efficacy of GH-replacement therapy can be monitored by assessing changes in body composition or in levels of GH-related peptides. In addition, patients should be monitored for the occurrence of adverse events.
机构:
Univ Queensland, Brisbane, Qld, Australia
Princess Alexandra Hosp, Dept Endocrinol & Diabet, Woolloongabba, Qld 4102, AustraliaUniv Queensland, Brisbane, Qld, Australia
Chikani, Viral
Cuneo, Ross C.
论文数: 0引用数: 0
h-index: 0
机构:
Princess Alexandra Hosp, Dept Endocrinol & Diabet, Woolloongabba, Qld 4102, AustraliaUniv Queensland, Brisbane, Qld, Australia
Cuneo, Ross C.
Hickman, Ingrid
论文数: 0引用数: 0
h-index: 0
机构:
Univ Queensland, Brisbane, Qld, Australia
Princess Alexandra Hosp, Dept Nutr & Dietet, Brisbane, Qld 4102, Australia
Mater Med Res Inst, Brisbane, Qld, AustraliaUniv Queensland, Brisbane, Qld, Australia
Hickman, Ingrid
Ho, Ken
论文数: 0引用数: 0
h-index: 0
机构:
Univ Queensland, Brisbane, Qld, Australia
Princess Alexandra Hosp, Dept Endocrinol & Diabet, Woolloongabba, Qld 4102, AustraliaUniv Queensland, Brisbane, Qld, Australia